Candidatus M. turicensis

Cat no. YSL-qP-IC-C.turicensis-100

Candidatus M. turicensis

Cat no. YSL-qP-IC-C.turicensis-100

A complete qPCR kit for the detection of Candidatus M. turicensis

M. turicensis is a pathogen commonly associated with feline infectious peritonitis (FIP), a fatal disease in cats. The causative agent, a feline coronavirus, leads to symptoms such as fever, weight loss, and fluid accumulation in the abdomen. This target is important to detect in the veterinary sector to prevent the spread of FIP and minimize the impact on cat populations.

YouSeq's qPCR kit to detect M. turicensis allows for rapid and accurate identification of the pathogen in feline samples. Early detection of this target is crucial in preventing the progression of FIP and implementing appropriate treatment measures to improve the health outcomes of infected cats. By using YouSeq's kit, veterinarians can efficiently diagnose and manage cases of FIP, ultimately reducing the burden on pet owners and the veterinary healthcare system.

United States FlagAvailable for delivery in United States

Price on enquiry

Order now

For Research Use Only. Not intended for diagnostic use.

Contents


Target Specific primer/probe
Internal extraction control primer/probe
qPCR MasterMix
Positive control template
DNase/RNase free water
Template resuspension buffer
Internal extraction control (DNA)
ROX passive reference

Technical specification


Target Gene(s):16S rRNA gene
Efficiency: 90-110%
Sensitivity: <100 copy detection
Run Time: Approx 1hr30 (dependent on instrumentation)
Target Pathogen: FAM labelled
Internal Control: VIC/HEX labelled

Product variants


YSL-qP-IC-C.turicensis-100 : Lyophilised version for ambient shipping
YS-qP-IC-C.turicensis-100 : Frozen version for dry ice shipping

Pseudonyms

Candidatus M. turicensis; Hemotropic Mycoplasma; Hemoplasma; Feline Hemotrophic Mycoplasma; Hemotropic Mycoplasma Turicensis; Cat Hemotropic Mycoplasma

Related products

More products

Still scrolling? We love adventurers

We work at the cutting edge of molecular biology, striving to disrupt our industry. We drive continuous product innovation and we aren’t afraid to take on new challenges.

More about us

Related learning resources